ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS IN PATIENTS WITH COLORECTAL CANCER UNDERGOING LAPAROSCOPIC SURGERY: INCIDENCE OF VENOUS THROMBOEMBOLISM AND BLEEDING COMPLICATIONS. THE PRO-LAPS STUDY.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01589146

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:20.182129+00:00

Published At

2012-05-01T00:00:00+00:00

Record Updated At

2012-05-01

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["The Primary Study Objective is to Assess the Efficacy and", "Safety of Extended 4-week Heparin Prophylaxis Compared to", "Prophylaxis Given for 8\u00b12 Days After Planned Laparoscopic", "Surgery for Colorectal Cancer.", "The Clinical Benefit Will be Evaluated as the Difference in", "the Incidence of VTE or VTE-related Death Occurring Within 30 Days", "From Surgery in the Two Study Groups."]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2012-05-01"

protocolSection.identificationModule.nctId

"NCT01589146"

protocolSection.identificationModule.officialTitle

"ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS IN PATIENTS WITH COLORECTAL CANCER UNDERGOING LAPAROSCOPIC SURGERY: INCIDENCE OF VENOUS THROMBOEMBOLISM AND BLEEDING COMPLICATIONS. THE PRO-LAPS STUDY."

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• The Primary Study Objective is to Assess the Efficacy and (protocolSection.conditionsModule.conditions)
• Safety of Extended 4-week Heparin Prophylaxis Compared to (protocolSection.conditionsModule.conditions)
• Prophylaxis Given for 8±2 Days After Planned Laparoscopic (protocolSection.conditionsModule.conditions)
• Surgery for Colorectal Cancer. (protocolSection.conditionsModule.conditions)
• The Clinical Benefit Will be Evaluated as the Difference in (protocolSection.conditionsModule.conditions)
• the Incidence of VTE or VTE-related Death Occurring Within 30 Days (protocolSection.conditionsModule.conditions)
• From Surgery in the Two Study Groups. (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.